Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
MiCo – Milano Congressi · Milan, Italy · June 16-19, 2018 Milan, Italy – I don’t know about you, but here at FDNA, we are extremely excited for an action-packed week full of presentations, posters, meetings, and, of course, gelato! Take a look below at our top picks of what to do and see […]
Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit in Boston, MA, FDNA CEO Dekel Gelbman will be featured among other thought leaders—Cansu Canca, Founder and Director of the AI Ethics Lab, and Adrian Gropper, CTO at Patient Privacy Rights—to discuss balancing ethics and […]
NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City. As with every element of the medical and scientific world, the pharmaceutical industry has nearly endless options for digital technology tools. The challenge becomes how to maximize those digital technologies during three critical stages: discovery, development, […]
Charlotte Convention Center · Charlotte, North Carolina · April 10-14, 2018 Charlotte, NC – The wait for ACMG is finally over! FDNA’s Face2Gene team is heading to Charlotte over the next few days and is growing anxious to share with you all that we have planned for our week down south. Take a look below at our […]
In its 44 year history, Greenwood Genetic Center (GGC) has seen over 80,000 patient cases. That’s a lot of data. And hiding in the mountains of information are insights sometimes invisible to the human eye, insights that artificial intelligence like the Face2Gene technologies can tease out from obscurity. At the Microsoft booth at HiMSS, Anthony […]
As over 40,000 health IT professionals, clinicians, executives, and vendors from around the world gather at this year’s HIMSS Annual Conference & Exhibition, speaker Anthony Antonuccio, VP of Product at FDNA shares FDNA’s experience with one of the leading clinics, Greenwood Genetic Center (GGC) in his talk, Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey. Discover […]
English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced the launch of the Genomics Collaborative. This initiative prompts clinicians, patients, advocates and researchers to join forces in an effort to accelerate breakthroughs in precision medicine. The Genomics Collaborative allows participants to access FDNA’s deep […]
In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only effective for 30-50% of patients. The reason? A “one-size-fits-all” approach to pharmaceutical development and commercialization. At this year’s 22nd Annual Drug Delivery Partnership meeting, a new approach to the pharma value chain is in discussion. […]
The American Society of Human Genetics 67th Annual Meeting (ASHG 2017) Orange County Convention Center · Orlando, Florida October 17-21, 2017 Orlando, FL – The Face2Gene team has started packing to attend the 67th ASHG Annual Meeting in sunny Orlando, FL. ASHG is the world’s largest gathering of human genetics professionals, bringing in members and […]